Eight million Americans signed up for private health insurance during the just-concluded first enrollment period under the Affordable Care Act.
Laparoscopic power morcellation may increase women's cancer risk, FDA says.
The FDA has approved a new indication for Arzerra to use in combination with chlorambucil, for the treatment of previously untreated patients with chronic lymphocytic leukemia.
The FDA has granted Orphan Drug designation to volasertib (Boehringer Ingelheim) for acute myeloid leukemia (AML).
AbbVie announced the initiation of a Phase 3 trial evaluating the safety and efficacy of veliparib in patients with previously untreated locally advanced or metastatic squamous non-small cell lung cancer.
Six percent of patients with colorectal cancer (CRC) have interval cancers, which develop within six to 60 months of colonoscopy.
The use of neoadjuvant and adjuvant chemotherapy for the treatment of muscle-invasive bladder cancer is associated with a survival benefit in the general population, and may be underutilized.
Higher hospital charge and increased length of stay for patients aged 80 years and older post-resection
High intake of saturated fats is associated with increased risk of certain subtypes of breast cancer.
With the resignation of U.S. Health and Human Services Secretary Kathleen Sebelius on Friday, the Affordable Care Act will get a fresh face.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|